These results indicate that treatment with HSP-NPs nanoparticles was able to completely normalize the elevated MDA levels in the depression model, restoring them to near-control values in both the cortex and hippocampus brain regions of diseased rats. Here, HSP90B2P is linked to depressive symptom measurement.